MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) announced it has engaged Venture Liquidity Providers (VLP) to provide market-making services for its common shares, subject to regulatory and final approvals. The service, to be conducted through W.D. Latimer Co. Ltd., aims to maintain an orderly trading market in compliance with Canadian Securities Exchange policies. Under the agreement, MindBio will pay $5,000 per month over a 12-month term, which may be terminated at any time. Both parties operate at arm’s length, and VLP holds no direct or indirect interest in the company or its securities.
MindBio is a biotechnology company that commercializes AI prediction technologies for drug and alcohol intoxication detection via voice analysis. Its AI model uses over 50 million data points to predict alcohol intoxication with remarkable accuracy using only the human voice. The company is developing an enterprise platform including Edge-AI kiosks that integrate bespoke hardware and software for detecting drug and alcohol intoxication across industries such as mining, aviation, construction, and law enforcement.
The engagement of VLP is significant for MindBio as it seeks to improve market liquidity and ensure a stable trading environment for its shares. Market-making services can help reduce volatility and provide investors with better opportunities to buy and sell shares, potentially increasing investor confidence and attracting more interest in the company. For a biotechnology firm focused on innovative AI-driven solutions, maintaining a liquid and orderly market is crucial for supporting its growth and financing activities.
Investors can find the latest news and updates on MBQIF in the company’s newsroom at https://ibn.fm/MBQIF. The full press release is available at https://ibn.fm/4evlA.
MindBio’s technology addresses a critical need for accurate, non-invasive intoxication detection in safety-sensitive environments. By leveraging voice analysis, the company aims to provide a scalable solution that can be deployed in various enterprise settings. The market-making agreement represents a strategic move to support the company’s visibility and accessibility in the capital markets as it advances its commercial objectives.
